Neural Mechanisms in Cardiorenal Regulation
心肾调节的神经机制
基本信息
- 批准号:8374561
- 负责人:
- 金额:$ 28.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountingAcuteAdrenergic AgentsAnimalsAttenuatedBaroreflexBypassCanis familiarisCardiacCardiovascular systemChronicClinicalDenervationElectric StimulationEssential HypertensionEvaluationExcretory functionFinancial compensationFunctional disorderGoalsHeart failureHumanHypertensionHypotensionIsotopesKidneyLightLimb structureLinkLong-Term EffectsMeasuresMediatingMethodologyMethodsNatureNerveNervous system structureNeuraxisNorepinephrineObesityOrganPathogenesisPatternPeripheralPhysiologicalPhysiologyPilot ProjectsPlasmaPlayPressoreceptorsProcessQuantitative EvaluationsReflex actionRegulationReportingRoleSeveritiesSignal TransductionSodiumSympathetic Nervous SystemTechniquesTechnologyTestingTimeadrenergicarmattenuationcarotid sinusdiscountindexinginnovationinsightinstrumentinterestneuromechanismnormotensivenovel strategiespressureresearch studyresponse
项目摘要
The sympathetic nervous system plays an important role in the pathogenesis of hypertension, yet the precise
determinants of sympathetic activation are unresolved. Furthermore, the efferent mechanisms that account for
long-term sympathetically-induced alterations in arterial pressure are unclear. In this regard, there is
considerable controversy as to whether alterations in renal excretory function are of paramount importance in
mediating the chronic effects of the nervous system on arterial pressure. In short, progress in understanding
the above issues has been limited by the lack of clinical and experimental methods for critically studying
sympathetic function in the chronic regulation of arterial pressure. Because of the crucial role of the baroreflex
in acute regulation of arterial pressure, there has been a long-standing interest in the possibility that
baroreflexes might chronically influence the level of sympathetic activity and arterial pressure in hypertension.
The potential importance of such a relationship has been highlighted by clinical observations demonstrating
that the sympathetic arm of the baroreflex is impaired in primary hypertension. However, because the
baroreflex resets in the direction of the ambient pressure, a role for the baroreflex in long-term pressure control
is often discounted. On the other hand, because of technical limitations, it is important to emphasize that there
is little empirical evidence from chronic studies that supports the notion that baroreflex resetting is complete in
hypertension. In fact, recent innovative studies in animals with experimentally-induced hypertension suggest
that the baroreflex does not totally reset and has sustained sympathoinhibitory effects in hypertension. These
studies further indicate baroreflex activation chronically suppresses renal sympathetic nerve activity and
promotes sodium excretion, responses expected to attenuate the severity of hypertension. The relevance of
these studies to clinical hypertension, however, is limited by their relatively short duration (most commonly one
week). In the proposed studies, we will use a novel approach to evaluate several aspects of baroreflex function
over at least 3 weeks of controlled baroreflex activation. We will use a combination of sophisticated techniques
in chronically instrumented dogs to determine whether the central nervous system contributes to chronic
resetting of the baroreflex and whether chronic activation of the baroreflex does indeed have sustained effects
to inhibit renal sympathetic nerve activity and promote sodium excretion. To achieve these goals, the carotid
baroreflex will be chronically activated by electrical stimulation of the carotid sinuses. Chronic electrical
activation of the carotid baroreflex leads to sustained suppression of sympathetic activity and arterial pressure
and is an ideal technique for determining the importance of central resetting in attenuating the
sympathoinhibition induced by increased baroreceptor activity because it allows for precise control of central
afferent input patterns. Additionally, in combination with other measures, this methodology permits direct
evaluation of the chronic effects of baroreflex activation on renal sympathetic outflow and excretory function.
Isotope dilution methodology will be used in these studies to determine whole body and renal norepinephrine
spillover to plasma as indices of central and renal specific sympathetic outflow. These studies will provide
unique insight into the chronic functional effects of the baroreflex in hypertension and the importance of the
kidneys in mediating long-term changes in-arterial pressure during alterations in central sympathetic outflow.
交感神经系统在高血压的发病机制中起着重要作用,但确切的
交感神经激活的决定因素尚未解决。此外,解释
长期交感神经诱导的动脉压变化尚不清楚。在这方面,
关于肾排泄功能的改变是否在肾衰竭中具有至关重要的意义,
调节神经系统对动脉压的慢性影响。简而言之,
由于缺乏临床和实验方法进行批判性研究,
交感神经在动脉压慢性调节中的作用。因为压力感受器反射的重要作用
在动脉压的急性调节中,长期以来人们对以下可能性感兴趣,
压力反射可能会长期影响高血压患者的交感神经活动水平和动脉压。
这种关系的潜在重要性已被临床观察所强调,
压力反射的交感神经臂在原发性高血压中受损。但由于
压力反射在环境压力的方向上重置,这是压力反射在长期压力控制中的作用
往往被低估。另一方面,由于技术限制,必须强调,
很少有来自慢性研究的经验证据支持压力反射重置是完全的这一观点,
高血压事实上,最近对实验性高血压动物的创新研究表明,
压力感受性反射在高血压中不会完全复位,并具有持续的交感神经抑制作用。这些
研究进一步表明压力反射激活长期抑制肾交感神经活动,
促进钠排泄,预期减轻高血压严重程度的反应。的相关性
然而,这些临床高血压的研究受到其相对较短的持续时间的限制(最常见的是
周)。在这些研究中,我们将使用一种新的方法来评估压力反射功能的几个方面
在至少3周的受控压力反射激活中。我们将使用复杂的技术
以确定中枢神经系统是否有助于慢性
压力感受器反射的重置以及压力感受器反射的慢性激活是否确实具有持续效应
抑制肾交感神经活动,促进钠排泄。为了实现这些目标,颈动脉
压力感受器反射将被颈动脉窦的电刺激慢性激活。慢性电
颈动脉压力感受器反射的激活导致交感神经活动和动脉压的持续抑制
并且是用于确定中枢复位在衰减脑电活动中的重要性的理想技术。
压力感受器活动增加引起的交感神经抑制,因为它允许精确控制中枢神经系统。
传入输入模式此外,结合其他措施,这种方法可以直接
评价压力反射激活对肾交感神经流出和排泄功能的慢性影响。
在这些研究中将使用同位素稀释法测定全身和肾脏去甲肾上腺素
溢出到血浆作为中枢和肾特异性交感神经流出的指标。这些研究将提供
独特的洞察力慢性功能的影响,压力反射在高血压和重要性,
在中枢交感神经流出改变期间,肾脏介导动脉压的长期变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS E LOHMEIER其他文献
THOMAS E LOHMEIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS E LOHMEIER', 18)}}的其他基金
NERVOUS SYSTEM MECHANISMS IN CIRCULATORY CONTROL
循环控制中的神经系统机制
- 批准号:
6242327 - 财政年份:1997
- 资助金额:
$ 28.64万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 28.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 28.64万 - 项目类别:
Operating Grants














{{item.name}}会员




